Skip to main content
メニュー
Revvity logo
Contact us

Loading...

JP
Search all

Loading...

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Knowledge Base
  • Newborn screening disorders
  • Trisomy 13 (Patau syndrome)
Common Trisomies

Trisomy 13 (Patau syndrome)

Background

Patau syndrome, also called trisomy 13, is a chromosomal disorder caused by the presence of an extra chromosome 13 in all or some of the cells.

  • In most cases, the third chromosome 13 is present in all cells (primary trisomy)
  • In other cases, an extra portion of chromosome 13 is attached to another chromosome (“unbalanced translocation”) which may be due to a balanced translocation in one parent
  • Another form of trisomy 13 is when the extra copy of chromosome 13 is only found in some cells while the other cells have the typical two copies (“mosaicism”)

Clinical diagnosis

Patau syndrome is a rare condition that typically causes significant intellectual disabilities, heart defects, developmental problems, weakness in muscles and other physical issues. The syndrome carries a high mortality rate: in utero death occurs in over 95% of fetuses with this chromosomal anomaly and only few babies survive to their first birthday. Profound mental retardation and developmental delay occur in survivors. Seizures and feeding difficulties are also common.

Testing

Testing for Patau syndrome can be performed during pregnancy, as early as the 1st trimester. Tests fall into two categories: either screening or diagnostic tests. While diagnostic tests can provide a definitive answer as to whether there is Patau syndrome or not, they are invasive and are thus associated with a small chance of miscarriage. Screening tests, on the other hand, are non-invasive (blood tests or ultrasounds) and thus have no associated increased risk for miscarriage. Although they are safe for the pregnancy, they are not diagnostic and can only say whether there is a high or low chance that the baby has Patau syndrome.

Treatment

Currently, there is no cure for Patau syndrome. Management of children with trisomy 13 is planned on a case-by-case basis and depends on the individual circumstances of the patient. The treatment of the syndrome focuses on the particular physical problems with which each child is born. Surgery may be necessary to repair heart defects or body abnormalities. Many infants do not survive the first few days or weeks due to severe neurological problems or complex heart defects.

Inheritance

Patau syndrome occurs in approximately 1 out of every 16,000 live-born infants. Most cases of Patau syndrome are sporadic and are not inherited. However, Patau syndrome caused by a translocation can be inherited. In this scenario, an unaffected carrier parent can have a rearrangement of genetic material between chromosome 13 and another chromosome. This is called a balanced translocation because there is no extra or missing material from the chromosomes. Although they do not have Patau syndrome, people who carry this type of balanced translocation are at an increased risk of having children with the condition.

Instruments for common trisomies screening

AutoDELFIA Revvity
AutoDELFIA immunoassay system for prenatal screening
Part number: 1235-5220
View details
Victor 2D 0312
VICTOR2 D Instrument
Part number: 1420-020
View details
Vanadis®, Vanadis Extract®, Vanadis Core®, Vanadis View®
Vanadis NIPT system
Part number: VANADISIVD
View details
3 of 3
ON THIS PAGE
  • Background
  • Clinical diagnosis
  • Testing
  • Treatment
  • Inheritance
  • Instruments for common trisomies screening
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.